Intravitreal Ranibizumab for Diabetic Macular Edema Patients with Good Baseline Visual Acuity: A Real-Life Study
INTRODUCTION[|] This is a report of 12-month real-life outcomes of ranibizumab treatment in diabetic macular edema (DME) patients who had a baseline visual acuity (VA) ≥0.6 in decimals.[¤]METHODS[|]Newly diagnosed treatment-naïve DME patients with a VA ≥0.6 who completed a follow...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
KARE Publishing
2017-10-01
|
| Series: | Beyoglu Eye Journal |
| Subjects: | |
| Online Access: | https://jag.journalagent.com/z4/download_fulltext.asp?pdir=beyoglu&un=BEJ-87598 |